Respiratory news

Three-quarters of COPD cases linked to childhood risk factors

Three-quarters of COPD cases linked to childhood risk factors

Chronic obstructive pulmonary disease (COPD) frequently...

SMART therapy linked to better asthma outcomes

SMART therapy linked to better asthma outcomes

Single maintenance and reliever therapy (SMART) is...

Increasing inhaled steroid doses may not prevent asthma exacerbations in children

Increasing inhaled steroid doses may not prevent asthma exacerbations in children

Children with mild to moderate asthma do not benefit...

MIMS Respiratory and Allergy Learning workshops 2018 - new Birmingham date announced

MIMS Respiratory and Allergy Learning workshops 2018 - new Birmingham date announced

A free full-day MIMS workshop in Birmingham has just...

New biologic for severe eosinophilic asthma

New biologic for severe eosinophilic asthma

Benralizumab (Fasenra) is the latest biologic to be...

Quadrupling steroid dose reduces risk of asthma exacerbations

Quadrupling steroid dose reduces risk of asthma exacerbations

Temporarily increasing the inhaled glucocorticoid dose...

New MIMS workshop announced launching the 2018 'Respiratory and Allergy Learning Series'

New MIMS workshop announced launching the 2018 'Respiratory and Allergy Learning Series'

A free full-day MIMS workshop has just been launched...

New once-daily triple combination inhaler for COPD

New once-daily triple combination inhaler for COPD

Trelegy Ellipta is the second 3-in-1 treatment for...

First NICE asthma guideline recommends oral treatment before LABA

First NICE asthma guideline recommends oral treatment before LABA

NICE suggests offering a leukotriene receptor antagonist...

Combined LABA/steroid inhaler added to Easyhaler range

Combined LABA/steroid inhaler added to Easyhaler range

Fobumix Easyhaler 320/9 (budesonide/formoterol) is...

New salmeterol/fluticasone MDI extends choice in asthma prescribing

New salmeterol/fluticasone MDI extends choice in asthma prescribing

Aloflute (salmeterol/fluticasone) metered dose inhaler...

NICE approves reslizumab for severe eosinophilic asthma

NICE approves reslizumab for severe eosinophilic asthma

NICE has approved the use of reslizumab (Cinqaero)...

First triple combination inhaler launched for COPD

First triple combination inhaler launched for COPD

Trimbow is a 3-in-1 treatment for chronic obstructive...

Oral COPD treatment approved for routine NHS use

Oral COPD treatment approved for routine NHS use

NICE has approved roflumilast (Daxas) for use within...

AirFluSal MDI: a new LABA/corticosteroid inhaler

AirFluSal MDI: a new LABA/corticosteroid inhaler

AirFluSal MDI (salmeterol/fluticasone) is indicated...

Inhaler options multiply with launch of new salmeterol/fluticasone MDI

Inhaler options multiply with launch of new salmeterol/fluticasone MDI

Sereflo (salmeterol/fluticasone) is indicated for adults...

Pictorial inhaler guide published on MIMS website

Pictorial inhaler guide published on MIMS website

Images and key features of inhalers and other respiratory...

Asthma and COPD Preparations and Compatible Devices

Asthma and COPD Preparations and Compatible Devices

Available presentations of bronchodilators and anti-inflammatories.

Inhalers, a Guide to Breath-Actuated Devices

Inhalers, a Guide to Breath-Actuated Devices

Key features of dry powder and aerosol inhalers.

Alternative salmeterol/fluticasone dry powder inhaler for asthma and COPD

Alternative salmeterol/fluticasone dry powder inhaler for asthma and COPD

Aerivio Spiromax provides the same metered dose of...

MIMS Product Slides

Product overviews prepared by the MIMS team, in a handy slide format.

Click here

Slides are initiated, funded & reviewed by the companies specified.

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more